Literature DB >> 22912355

Fluorescence in situ hybridization study of chromosome abnormalities of upper urinary tract urothelial carcinoma in paraffin-embedded tissue.

Zhanyong Bing1, Jinhong Li, Stephen R Master, Chyi-chia Lee, Raghunath Puthiyaveettil, John E Tomaszewski.   

Abstract

Urothelial carcinomas arising from the upper urinary tract (renal pelvis and ureter) are rare and few molecular genetic studies of these tumors have been conducted to date. We investigated hyperploidy at chromosomes 3, 7, and 17 using a multitarget fluorescence in situ hybridization system to identify genetic alterations in patients with urothelial carcinomas of the upper urinary tract. Chromosomal aberrations are seen most frequently in the high-grade tumors. A highly significant relationship was found between an increase in the percentage of hyperdiploidy and high grade for each chromosome (chromosome 3, P = 6 × 10(-4); chromosome 7, P = 2 × 10(-4); chromosome 17, P = 6 × 10(-5)). To determine whether these associations were independent for each chromosome, the correlation between percentage of hyperdiploidy for each pair of chromosomes was examined. In each case, the correlation was highly significant (R = 0.89-0.91). No statistically significant association was found between percentage of hyperdiploidy and tumor stage for any chromosome.

Entities:  

Mesh:

Year:  2012        PMID: 22912355     DOI: 10.1309/AJCPUXAP6P2GVBTI

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison.

Authors:  Thomas Sanford; Sima Porten; Maxwell V Meng
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

2.  Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.

Authors:  Danijel Sikic; Bastian Keck; Sven Wach; Helge Taubert; Bernd Wullich; Peter J Goebell; Andreas Kahlmeyer; Peter Olbert; Philipp Isfort; Wilhelm Nimphius; Arndt Hartmann; Johannes Giedl
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.